The Age of Infinite explores topics related to the emergence of infinite opportunities to improve life for all species through Mearth, our accelerating Moon-and-Earth based ecosystem. Fascinating, innovative, paradigm-shifting content is shared by experts in space, commerce, science, government, and the environment to enlighten, educate, inspire, and dare listeners to think bigger about infinite possibilities for the future.
Episodes
Monday Feb 18, 2019
Monday Feb 18, 2019
In This Episode
Join host David Goldsmith as he welcomes Yossi Yamin, the director of SpacePharma, a pioneering startup from Israel that is revolutionizing the way we conduct experiments in space. Yossi shares groundbreaking insights on how microgravity and unique conditions in orbit enable the creation of new molecular structures that could change medicine and materials science forever.
Throughout the episode, Yossi discusses the innovative use of CubeSats—miniaturized laboratories that can perform complex experiments in space at a fraction of the cost of traditional methods. He highlights specific experiments, such as protein crystallization, peptide self-assembly, and neuron extension, showcasing how these processes yield results that are unattainable on Earth.
The conversation takes unexpected turns as Yossi reveals the implications of these advancements for personal medicine, including efforts to develop tailored treatments for conditions like Parkinson's disease. As they explore these themes, listeners will gain a deeper understanding of how space technology can lead to significant breakthroughs in healthcare and beyond.
Episode Outlines
- Introduction to Yossi Yamin and SpacePharma
- The concept of CubeSats and miniaturized laboratories
- Protein crystallization in microgravity
- Peptide self-assembly and its implications
- Axon neuron extension: growing neurons in space
- The role of low atmosphere and microgravity in experimentation
- Case studies: experiments conducted with various clients
- Challenges and opportunities in the space industry
- The future of personalized medicine from space research
- Conclusion: The potential impact of space-based research on Earth
Biography of the Guest
Yossi Yamin is the director of SpacePharma, an innovative startup based in Israel focused on conducting scientific research in microgravity. With a background in molecular biology and extensive experience in biotechnology, Yossi has been at the forefront of developing new technologies that leverage the unique conditions of space for groundbreaking scientific discoveries.
Under his leadership, SpacePharma has successfully executed multiple experiments aboard CubeSats, exploring areas such as protein crystallization and peptide self-assembly. Yossi's work aims to bridge the gap between space exploration and practical applications on Earth, particularly in pharmaceuticals and personalized medicine.
His vision includes creating a factory in orbit capable of producing high volumes of novel compounds derived from space-based research, ultimately contributing to advancements in healthcare and sustainable living on Earth.
The themes in today’s episode are just the beginning. Dive deeper into innovation, interconnected thinking, and paradigm-shifting ideas at www.projectmoonhut.org—where the future is being built.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.